The study findings indicate a peculiar pathway of regulation of hair growth by hair stem cells that is mediated by dermal melanocytes in senescence.
Lilly’s Zepbound wins the weight loss duel with Novo’s Wegovy
Lilly’s Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide 1 (GLP-1) receptor agonist while Novo’s Wegovy is a GLP-1 receptor agonist.